ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
| 21.80 Delayed Data As of Dec 08 |  +0.46 / +2.16%Today’s Change | 15.68 Today|||52-Week Range 57.34 | -59.22% Year-to-Date |
Latest ACAD News | Press Releases
| Acadia Pharma Shares Jump on Positive Test Results for Rett's Drug Dec 08 / GuruFocus News - Paid Partner Content | ACADIA's (ACAD) Rett Syndrome Candidate Meets Goal in Study Dec 07 / Zacks.com - Paid Partner Content |
| Is It Time to Buy the Nasdaq's 11 Worst-Performing Stocks of 2021? Dec 08 / MotleyFool.com - Paid Partner Content | Why Acadia Pharmaceuticals Stock Is Rocketing Today Dec 07 / MotleyFool.com - Paid Partner Content |
| Biotech Stock Roundup: ACAD Up on Study Results, BHVN's Pipeline Update & More Dec 08 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 21.32 |
| Today’s open | 21.59 |
| Day’s range | 21.12 - 21.96 |
| Volume | 1,597,675 |
| Average volume (3 months) | 1,345,322 |
| Market cap | $3.2B |
Data as of 4:00pm ET, 12/08/2021
Growth & Valuation
| Earnings growth (last year) | -11.99% |
| Earnings growth (this year) | +43.07% |
| Earnings growth (next 5 years) | +4.07% |
| Revenue growth (last year) | +30.28% |
| P/E ratio | NM |
| Price/Sales | 19.04 |
| Price/Book | 5.07 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| INSMInsmed Inc | +0.40 | +1.42% |
| GLPGGalapagos NV | -0.58 | -1.12% |
| ARNAArena Pharmaceutical... | +2.05 | +3.89% |
| ---- |
Data as of 3:59pm ET, 12/08/2021
Financials
| Next reporting date | March 1, 2022 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $441.8M |
| Annual profit (last year) | -$281.6M |
| Net profit margin | -63.74% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
